Literature DB >> 11773513

Total fat and (n-3):(n-6) fat ratios influence eicosanoid production in mice.

K Shane Broughton1, John W Wade.   

Abstract

Previous studies have not addressed the effect of differing fat intake on the effectiveness of varying (n-3) polyunsaturated fatty acid (PUFA) ingestion in altering tissue composition and eicosanoid production. This study examined (n-3):(n-6) PUFA ratios of 0, 0.1:1, 0.2:1, 0.4:1, and 1:1 with total fat at 5, 10, 15, and 20 g/100 g of diet and (n-6) PUFA fixed at 1.5 g/100 g of diet on tissue composition and peritoneal cell eicosanoid response to an in vivo inflammatory stimulus in 240 mice. Both (n-3) PUFA and total fat intake influenced tissue composition and eicosanoid biosynthesis. Increased (n-3) PUFA intake was associated with an increase in tissue (n-3) PUFA and a decrease in long-chain (n-6) PUFA. Although hepatic tissue linoleic acid (LA) was not altered by (n-3) PUFA intake or changes in total fat, peritoneal cell LA increased in response to increasing total fat but was unaffected by changes in dietary (n-3) PUFA. Four-series leukotrienes (LT) decreased progressively with increased (n-3) PUFA at all fat intake levels. In addition, four-series LT decreased with increased total fat at low (n-3):(n-6) ratios (0 and 0.1). At high (n-3):(n-6) ratios (0.4 and 1.0) increasing dietary fat between the 5 and 15 g/100 g diets increased four-series LT synthesis, which reached a plateau between 15 and 20 g fat/100 g diets. Five-series LT production generally rose with increased (n-3) PUFA intake; this effect was most evident in mice fed the 5 g fat/100 g diet. Increasing total dietary fat at the three highest (n-3):(n-6) ratios (0.2, 0.4, 1.0) decreased five-series LT production. Elevated (n-3) PUFA and total fat intake exerted an additive effect with respect to prostacyclin (PGI(2)) production because it was reduced with increasing intakes of both. Compared with the mice consuming the no (n-3) 5 g/100 g diets, PGI(2) levels were reduced by 88% in mice consuming the highest total fat and (n-3) PUFA diets. At low fat intake (5 and 10 g/100 g diet), increasing the (n-3) PUFA intake was associated with a decrease in PGE(2) synthesis. However, unlike PGI(2), high fat intake reduced PGE(2) to basal levels with no further reduction induced by increased (n-3) PUFA intake.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11773513     DOI: 10.1093/jn/132.1.88

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  21 in total

1.  Effect of cyclooxygenase genotype and dietary fish oil on colonic eicosanoids in mice.

Authors:  Andrew P Neilson; Zora Djuric; Jianwei Ren; Yu H Hong; Ananda Sen; Corey Lager; Yan Jiang; Shony Reuven; William L Smith; Dean E Brenner
Journal:  J Nutr Biochem       Date:  2011-09-19       Impact factor: 6.048

Review 2.  The Mediterranean diet: effects on proteins that mediate fatty acid metabolism in the colon.

Authors:  Zora Djuric
Journal:  Nutr Rev       Date:  2011-12       Impact factor: 7.110

3.  Interaction of fatty acid genotype and diet on changes in colonic fatty acids in a Mediterranean diet intervention study.

Authors:  Shannon R Porenta; Yi-An Ko; Stephen B Gruber; Bhramar Mukherjee; Ana Baylin; Jianwei Ren; Zora Djuric
Journal:  Cancer Prev Res (Phila)       Date:  2013-09-10

4.  Development of exchange lists for Mediterranean and Healthy Eating diets: implementation in an intervention trial.

Authors:  E Sidahmed; M L Cornellier; J Ren; L M Askew; Y Li; N Talaat; M S Rapai; M T Ruffin; D K Turgeon; D Brenner; A Sen; Z Djuric
Journal:  J Hum Nutr Diet       Date:  2013-09-20       Impact factor: 3.089

5.  Influence of trans fatty acids on glucose metabolism in soleus muscle of rats fed diets enriched in or deprived of linoleic acid.

Authors:  Ana C Fariña; Sandro Hirabara; Juliana Sain; Marcela González; Rui Curi; Claudio Bernal
Journal:  Eur J Nutr       Date:  2017-03-11       Impact factor: 5.614

6.  Effects of fish oil supplementation on eicosanoid production in patients at higher risk for colorectal cancer.

Authors:  Maya N White; Martha J Shrubsole; Qiuyin Cai; Timothy Su; Jennings Hardee; John-Anthony Coppola; Sunny S Cai; Stephanie M Martin; Sandra Motley; Larry L Swift; Ginger L Milne; Wei Zheng; Qi Dai; Harvey J Murff
Journal:  Eur J Cancer Prev       Date:  2019-05       Impact factor: 2.497

7.  Streptozotocin-induced diabetes partially attenuates the effects of a high-fat diet on liver and brain fatty acid composition in mice.

Authors:  Beth Levant; Marlies K Ozias; Brianne L Guilford; Douglas E Wright
Journal:  Lipids       Date:  2013-07-28       Impact factor: 1.880

Review 8.  The rationale for the use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease.

Authors:  Ivan R Diamond; Anca Sterescu; Paul B Pencharz; Paul W Wales
Journal:  Pediatr Surg Int       Date:  2008-05-27       Impact factor: 1.827

Review 9.  Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease.

Authors:  Matteo Nicola Dario Di Minno; Anna Russolillo; Roberta Lupoli; Pasquale Ambrosino; Alessandro Di Minno; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2012-11-07       Impact factor: 5.742

10.  Transitions at CpG dinucleotides, geographic clustering of TP53 mutations and food availability patterns in colorectal cancer.

Authors:  Fabio Verginelli; Faraz Bishehsari; Francesco Napolitano; Mahboobeh Mahdavinia; Alessandro Cama; Reza Malekzadeh; Gennaro Miele; Giancarlo Raiconi; Roberto Tagliaferri; Renato Mariani-Costantini
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.